CHO technology speeds up productivity
11-Jul-2011 By Natalie Morrison
Developments in the field of Chinese Hamster Ovary (CHO) based biomanufacturing this week with new products from SAFC and BD Biosciences.
New synthetic cell membranes set to cut time and costs
11-Jul-2011 By Natalie Morrison
Costly and time consuming drug screening could soon be a thing of the past thanks to new easy-bake synthetic cell membranes made at the Institute of Materials Research and Engineering (IMRE).
UBC's vision for new diabetic retinopathy delivery device
06-Jul-2011 By Natalie Morrison
Scientists at the University of British Columbia have pioneered a magnetic retinal implant that can supply a regulated and on-demand release of drugs to treat blindness from diabetic retinopathy.
Second partnership for Fujifilm and Mitsubishi
05-Jul-2011 By Natalie Morrison
Fujifilm and Mitsubishi have embarked on a joint business venture in the contract manufacturing for biopharmaceuticals.
EMA OK for second Shire Replagal plant
05-Jul-2011 By Gareth Macdonald
Shire has received European Medicines Agency (EMA) approval for a new US plant, doubling purification capacity for its Fabry disease drug Replagal.
Appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB – People on the move
30-Jun-2011 By Gareth Macdonald
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
BioMarin to buy Pfizer’s Shanbally biologics plant
27-Jun-2011 By Gareth Macdonald
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Neuland to launch commercial-scale peptide manufacturing
23-Jun-2011 By Gareth Macdonald
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Pall expands Allegro mixer range
21-Jun-2011 By Gareth Macdonald
Processing technology firm Pall Life Sciences has introduced a 200L version of its Allegro single-use mixer for biopharmaceutical manufacturing.
Mystic awarded key manufacturing patent for delivery tech
Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.
NeoStem’s China antibiotics unit gets expanded SFDA approval
14-Jun-2011 By Gareth Macdonald
US stem-cell therapy firm NeoStem predicts that output of its China-based generic antibiotics subsidiary Suzhou Erye Pharmaceutical will increase after further manufacturing approval from the SFDA.
SSB and Sudpack team on plastic films for biologics production
Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.
Biopharma revenues key to Pall’s Q3 gains
13-Jun-2011 By Gareth Macdonald
Sales to the biopharmaceutical sector drove revenue growth at Pall in third quarter fiscal 2011 and will be key to the firm’s future says CEO.
Unilife says device selected for new biologic trial
09-Jun-2011 By Gareth Macdonald
Unilife says its one of its technologies has been selected as the delivery device for a biologic drug in an upcoming clinical trial.
Lonza announces CHF10m Singapore biomanufacturing expansion
08-Jun-2011 By Gareth Macdonald
Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
Xcellerex wins new customers for manufacturing techs
06-Jun-2011 By Gareth Macdonald
Biomanufacturing technology firm Xcellerex has had a good start to June with R-Pharm and Fujifilm Diosynth signing up as customers.
Bilfinger Berger wins €30m deal for work on Genzyme plant
01-Jun-2011 By Nick Taylor
Bilfinger Berger has won a €30m ($43m) contract to help Genzyme add 8,000L of production capacity at its site in Geel, Belgium.
Elan invests $20m in Proteostasis to pursue neurology drugs
30-May-2011 By Alexandria Pesic
Irish pharma giant Elan is investing $20m (€14m) in US drug developer Proteostasis Therapeutics to speed the research and development of disease modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders.
Changing Times: The Need For a Logical Sourcing Strategy
30-May-2011 By Lee S. Scheible, RPh., CA-AM and Jeffrey S Kasher, PhD
Sponsors need to abandon the ‘single trial, random, tactical sourcing approach’ in favour of a model flexible enough for a variety of study designs and research needs according to Eli Lilly experts Lee Scheible and Jeffrey S Kasher in this exclusive guest...
PolyPid launches combined polymer-lipid delivery tech
PolyPid claims its new polymer-lipid combination delivery tech will let pharmas set precise release characteristics for a variety of small molecule, protein and nucleic acid-base drugs.
Goodwin Biotechnology and Rafagen team on cell line manufacturing
26-May-2011 By Alexandria Pesic
Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.
Novozymes Biopharma to launch new ophthalmic HA grade
19-May-2011 By Gareth Macdonald
Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid (HA) for ophthalmic delivery applications later this year.
CMO Gallus buys Centocor bio facility and plans investment
19-May-2011 By Nick Taylor
CMO Gallus BioPharmaceuticals has bought, and is investing in, a Centocor biologics facility after receiving private equity backing.
Life Technologies releases range of ‘molecule-to-market’ bioproduction solutions
18-May-2011 By Alexandria Pesic
Californian biotech tool manufacturer Life Technologies has teamed with German contract research organisation (CRO) ProBiogen to release a range of royalty-free Gibco Freedom Cell Line Development Kits.
CMO expansion and deals news round up
17-May-2011 By Nick Taylor
Outsourcing-Pharma presents a round up of CMO expansions and deals, including news from Lonza, Dalton Pharma Services and Althea Technologies.
PBS Biotech launches PBS 3 single-use Bioreactor system
16-May-2011 By Alexandria Pesic
Californian Bioreactor manufacturer, PBS Biotech, has launched its new PBS 3 single-use bioreactor system for the development of biological therapeutics, vaccines and biosimilars.
Biobetter biotechs emerge as preclinical services clients
16-May-2011 By Nick Taylor
Biotechs set up to take an existing biologic, improve it and license the resulting biobetter are an emerging client for preclinical service providers.
SSB launches small-scale disposable reactor
Sartorius Stedim Biotech (SSB) has launched a new small-scale bioreactor citing growing biopharmaceutical company demand for scale-up technologies as the key driver for its development.
DavosPharma teams with Immunologix on 100% human MAbs for discovery
10-May-2011 By Gareth Macdonald
Chemistry services provider DavosPharma has added 100 per cent human antibodies to its discovery offering through a new alliance with Immunologix.
PPD expands consulting services into four new areas
10-May-2011 By Alexandria Pesic
North Carolina, US-based contract research organisation (CRO), PPD, has expanded its product development consulting services into four new areas.
Packaging components drive solid Q1 growth at West
02-May-2011 By Nick Taylor
Strong first quarter performance at the packaging unit helped West beat expectations but there were CZ and Delivery Systems disappointments.
Biocon CRO revenues jump as B-MS deal ramps up
28-Apr-2011 By Nick Taylor
Biocon contract research revenues jumped 20 per cent in the fourth quarter as a relationship with B-MS ramped up.
Eli Lilly and Medtronic to collaborate on developing new Parkinson’s treatment
27-Apr-2011 By Alexandria Pesic
Pharma giant Eli Lilly and medical device maker Medtronic are to collaborate on the research and development of an implantable drug delivery system for the treatment of Parkinson’s disease.
Caliber opens world’s largest plant-based manufacturing facility
26-Apr-2011 By Alexandria Pesic
US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
Appointments at Catalent, Novella and Publicis – People on the move
21-Apr-2011 By Nick Taylor
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.
Round up of M&A in pharma contract services
19-Apr-2011 By Nick Taylor
Outsourcing-Pharma presents a round up of contract services merger and acquisition activity, including deals at Evotec, Vyteris and Avantium Pharma.
West says Crystal Zenith syringe is solution to pharmas' glass delamination problem
14-Apr-2011 By Alexandria Pesic
West Pharmaceutical Services is preparing to increase its manufacturing capacity in response to an increased demand for its Daikyo Crystal Zenith 1mL syringe system.
Appointments at A10, Crystal Pharmatech and Algos – People on the move
14-Apr-2011 By Nick Taylor
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at A10, Crystal Pharmatech and Algos.
A new role for former Genzyme CEO and a leadership change at Astellas Europe – People on the move
13-Apr-2011 By Nick Taylor
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new role for former Genzyme CEO and a leadership change at Astellas Europe.
PanGen & Compass ink supply deal for biobetter APIs
PanGen Biotech is to supply Compass Biotechnologies with APIs for biobetters after signing a memorandum of understanding (MOU).
Biobetters a big opportunity for biopharm and CROs
12-Apr-2011 By Nick Taylor
Biobetters, more than biosimilars, are the big opportunity for biopharm and CROs hoping to profit from biologics patent expirations, say experts.
Chiltern expands European operations; opens new Netherlands office
04-Apr-2011 By Alexandria Pesic
Chiltern International, a global contract research organisation (CRO) has expanded its European operations with the opening of a new office in the Netherlands.
VisualSonics unveils ‘revolutionary’ Vevo LAZR imaging system
30-Mar-2011 By Alexandria Pesic
VisualSonics, a high-resolution micro imaging systems manufacturer, has launched a new imaging system it claims will revolutionise cancer research.
Almac co-invests in cold storage capacity with US client
28-Mar-2011 By Gareth Macdonald
Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals, continuing the contract manufacturing organisation’s (CMO) busy expansion programme.
UK CROs extend preclinical cancer partnership
24-Mar-2011 By Gareth Macdonald
Preclinical Oncology Services Limited (Precos) will to work with discovery services firm Argenta Discovery on cancer drug development projects under a revised collaboration agreement announced late yesterday.
Lonza wins manufacturing deals with Enobia and Athera
23-Mar-2011 By Gareth Macdonald
Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.
Appointments at PharmStar, Cephalon, Covidien and Catalent – People on the move
22-Mar-2011 By Nick Taylor
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PharmStar, Cephalon, Covidien and Catalent.
Inovio receives DNA vaccine delivery grant
21-Mar-2011 By Nick Taylor
Inovio has received a US grant to investigate delivering DNA vaccines to different parts of the body at the same time.
Appointments at Catalent, Cytel and Laureate Biopharmaceutical – People on the move
21-Mar-2011 By Nick Taylor
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Cytel and Laureate Biopharmaceutical.
Therapeutic Ab deals: ChemPartner partners with Shenogen; Morphosys teams with Boehringer
17-Mar-2011 By Alexandria Pesic
Shanghai-based CRO, ChemPartner, a subsidiary of Chinese biotech outsourcing company, ShangPharma, has signed a research services agreement with China-based oncology specialists, Shenogen Pharma, to develop therapeutic antibodies for use in the treatment...